A cure for a race? Heart drug findings set off ethics debate.
Payne
January W
JW
D001741:Black or African American / Q000235:genetics*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics; D006801:Humans; D006830:Hydralazine / Q000378:metabolism / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000378:metabolism / Q000627:therapeutic use; D008389:Marketing of Health Services; D010597:Pharmacogenetics; D044469:Racial Groups / Q000235:genetics; D016896:Treatment Outcome; D014481:United States
D004338:Drug Combinations; D015507:Drugs, Investigational; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate